Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infection

The combination rilpivirine (RPV)/emtricitabine (FTC)/tenofovir (TDF) is a once-daily, single-tablet regimen (STR) containing one nonnucleoside reverse-transcriptase inhibitor associated with two nucleos(t)ide reverse transcriptase inhibitors. It is approved by regulatory agencies (eg, US Food and D...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardini, Claudia, Maggiolo, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693919/
https://www.ncbi.nlm.nih.gov/pubmed/23814462
http://dx.doi.org/10.2147/PPA.S28797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693919/
https://www.ncbi.nlm.nih.gov/pubmed/23814462
http://dx.doi.org/10.2147/PPA.S28797

Ejemplares similares